Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Cost-effectiveness of ranolazine added to standard-of-care treatment in patients with chronic stable angina pectoris.

Kohn CG, Parker MW, Limone BL, Coleman CI.

Am J Cardiol. 2014 Apr 15;113(8):1306-11. doi: 10.1016/j.amjcard.2014.01.407.

PMID:
24560062
2.

Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective.

Coleman CI, Freemantle N, Kohn CG.

BMJ Open. 2015 Nov 6;5(11):e008861. doi: 10.1136/bmjopen-2015-008861.

3.

Cost-utility of ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Spain.

Hidalgo-Vega A, Ramos-Goñi JM, Villoro R.

Eur J Health Econ. 2014 Dec;15(9):917-25.

PMID:
24122303
4.

Ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Greece: a cost-utility study.

Kourlaba G, Vlachopoulos C, Parissis J, Kanakakis J, Gourzoulidis G, Maniadakis N.

BMC Health Serv Res. 2015 Dec 18;15:566. doi: 10.1186/s12913-015-1228-y.

5.

Clinical experience with ranolazine in a veteran population with chronic stable angina.

Reeder DN, Gillette MA, Franck AJ, Frohnapple DJ.

Ann Pharmacother. 2012 Jan;46(1):42-50. doi: 10.1345/aph.1Q487.

PMID:
22215689
6.

Impact of angina frequency on health utility values of patients with chronic stable angina.

Kohn CG, Parker MW, Limone BL, Coleman CI.

Health Qual Life Outcomes. 2014 Mar 14;12:39. doi: 10.1186/1477-7525-12-39.

7.

Effectiveness of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina according to baseline hemoglobin A1c.

Arnold SV, McGuire DK, Spertus JA, Li Y, Yue P, Ben-Yehuda O, Belardinelli L, Jones PG, Olmsted A, Chaitman BR, Kosiborod M.

Am Heart J. 2014 Oct;168(4):457-465.e2. doi: 10.1016/j.ahj.2014.06.020.

PMID:
25262254
8.

Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina).

Kosiborod M, Arnold SV, Spertus JA, McGuire DK, Li Y, Yue P, Ben-Yehuda O, Katz A, Jones PG, Olmsted A, Belardinelli L, Chaitman BR.

J Am Coll Cardiol. 2013 May 21;61(20):2038-45. doi: 10.1016/j.jacc.2013.02.011.

9.
10.

A literature review to evaluate the economic value of ranolazine for the symptomatic treatment of chronic angina pectoris.

Vellopoulou K, Kourlaba G, Maniadakis N, Vardas P.

Int J Cardiol. 2016 May 15;211:105-11. doi: 10.1016/j.ijcard.2016.02.140. Review.

PMID:
26994453
11.

Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.

Stone PH, Gratsiansky NA, Blokhin A, Huang IZ, Meng L; ERICA Investigators..

J Am Coll Cardiol. 2006 Aug 1;48(3):566-75.

12.

Ranolazine (Ranexa) for chronic stable angina.

Ndegwa S.

Issues Emerg Health Technol. 2007 Jun;(99):1-6.

PMID:
17595750
13.
14.

Ranolazine for the treatment of refractory angina in a veterans population.

Greene RS, Rangel RM, Edwards KL, Chastain LM, Brouse SD, Alvarez CA, Collins LJ, Brilakis ES, Banerjee S.

Cardiovasc Revasc Med. 2012 Mar-Apr;13(2):141.e1-5. doi: 10.1016/j.carrev.2011.06.001.

15.

The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials.

Banon D, Filion KB, Budlovsky T, Franck C, Eisenberg MJ.

Am J Cardiol. 2014 Mar 15;113(6):1075-82. doi: 10.1016/j.amjcard.2013.11.070. Review.

PMID:
24462341
16.

Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial.

Arnold SV, Morrow DA, Wang K, Lei Y, Mahoney EM, Scirica BM, Braunwald E, Cohen DJ; MERLIN-TIMI 36 Investigators..

Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):107-15. doi: 10.1161/CIRCOUTCOMES.108.798009.

17.
18.
19.

Ranolazine: new drug. Stable angina: not worth the risk.

[No authors listed]

Prescrire Int. 2009 Aug;18(102):148-7.

PMID:
19743543
20.

Efficacy and safety of ranolazine in patients with chronic stable angina.

Kloner RA, Hines ME, Geunes-Boyer S.

Postgrad Med. 2013 Nov;125(6):43-52. doi: 10.3810/pgm.2013.11.2711. Review.

PMID:
24200760

Supplemental Content

Support Center